Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study (P4-6.014).

Neurologyยท2025
Same author

Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraceptionยท2024
Same author

Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapies.

Multiple sclerosis and related disordersยท2024
Same author

Expert opinion on the use of contraception in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)ยท2024
Same author

Ocrelizumab in highly disabled progressive multiple sclerosis patients.

Multiple sclerosis and related disordersยท2024
Same author

Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.

Multiple sclerosis journal - experimental, translational and clinicalยท2023

Related Experiment Video

Updated: May 11, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Multiple sclerosis and pregnancy.

Maria Houtchens1

  • 1Brigham and Women's Hospital, Harvard Medical School, Brookline, Massachusetts, USA. mhoutchens@partners.org

Clinical Obstetrics and Gynecology
|May 2, 2013
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) relapse risk decreases during pregnancy but rises postpartum. This review guides counseling women with MS on family planning and reproductive health management.

More Related Videos

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: May 11, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Area of Science:

  • Neurology
  • Reproductive Medicine
  • Women's Health

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease impacting adults of reproductive age.
  • MS relapse rates decrease during pregnancy and significantly increase postpartum.
  • Delivery method, anesthesia, and parity do not influence postpartum MS relapse risk.

Purpose of the Study:

  • To provide current information and guidelines for counseling patients with MS who desire motherhood.
  • To address knowledge gaps regarding long-term pregnancy effects on MS outcomes.
  • To explore the impact of lactation on postpartum MS relapses and optimal management strategies.

Main Methods:

  • This study is a comprehensive literature review.
  • It synthesizes existing research on pregnancy, postpartum, and lactation in women with MS.
  • Guidelines are formulated based on current evidence for patient counseling.

Main Results:

  • Pregnancy is associated with a reduced risk of MS relapses.
  • The postpartum period, particularly the first 3-6 months, shows an increased risk of MS relapse.
  • Key areas requiring further research include long-term pregnancy impacts and lactation effects.

Conclusions:

  • Women with MS can be counseled on family planning with current knowledge of pregnancy and postpartum relapse risks.
  • Further research is needed to fully understand the reproductive cycle's impact on MS.
  • Evidence-based guidelines are essential for managing MS patients through their reproductive journey.